TMCnet News
Novartis establishes strategic alliance with Quebec artificial intelligence institute Mila
DORVAL, QC, Nov. 20, 2019 /CNW/ - Novartis Pharmaceuticals Canada Inc. announced today a strategic alliance with Mila as the company embraces the next chapter of healthcare innovation with new digital technologies and data science. This alliance with Mila underpins the Novartis commitment to leverage data and artificial intelligence (AI) to transform how medicines are discovered, developed and commercialized. This news was announced formally on the heels of the Innovative Medicines Canada annual general meeting in Montreal and was acknowledged by Quebec's Minister of Economy and Innovation, Minister Pierre Fitzgibbon. "This collaboration between Novartis and Mila will no doubt contribute to the advancement of the pharmaceutical industry and the artificial intelligence ecosystem in Quebec. I look forward to the progress and innovation that will come from it and will certainly bring the healthcar sector to new heights," said Minister Fitzgibbon. As part of the strategic relationship Novartis has committed to a three-year corporate presence at Mila's O Mile Ex complex in Montreal. "By having a presence at Mila, Novartis will be able to participate actively in its unique and dynamic ecosystem of companies, researchers and entrepreneurs. Alliances like this will help us go beyond the traditional pharmaceutical industry operating model to embrace the future of healthcare innovation to deliver on our purpose to reimagine medicine to improve and extend lives," said Christian Macher, President, Novartis Pharmaceuticals Canada Inc. The future is exciting as Novartis continues to evolve into a focused medicines company powered by advanced therapy platforms and data science. "The arrival of Novartis to this AI ecosystem is a game-changer and sends a strong message about how innovating means thinking differently. It's time to approach healthcare from a different angle. We applaud Novartis for being the first pharmaceutical company to work with us towards connecting AI strategies to healthcare solutions," said Yoshua Bengio, Founder and Scientific Director of Mila. About Novartis Pharmaceuticals Canada About Novartis SOURCE Novartis Pharmaceuticals Canada Inc. |